ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
70.13
+0.11 (0.16%)
At close: Aug 8, 2025, 4:00 PM
69.95
-0.18 (-0.26%)
After-hours: Aug 8, 2025, 7:54 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $5.32 billion as of August 8, 2025. Its market cap has increased by 605.48% in one year.
Market Cap
5.32B
Enterprise Value
5.33B
1-Year Change
605.48%
Ranking
Category
Stock Price
$70.13
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $5.32B, an increase of 2,260.89%. That is a compound annual growth rate of 36.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 5.32B | 1,100.87% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |